Meet the Team

Dr. Yuan is a practicing physician with firsthand experience treating patients affected by chronic skin conditions. His direct connection to patient care brings clinical relevance and urgency to DermalBright’s mission of developing targeted, science-driven therapies for underserved dermatologic diseases. In addition to his medical practice in Rockville Maryland, Dr. Yuan has a strong background in biomedical research, with numerous peer-reviewed publications spanning both clinical and translational science. He leads the company with a dual focus on scientific rigor and real-world patient impact.

Dr. Jia has over 20 years of extensive experience in biologic drug development, CMC regulatory review for INDs and BLAs, and GMP inspections. Throughout her career, she has guided numerous global companies through successful FDA inspections. During her tenure at the US FDA, Dr. Jia served as a senior CMC reviewer for IND/BLA submissions and carried out pre-approval and prelicensing inspections of biological products in the Office of Biotechnology Products under CDER. Furthermore, she co-instructed the annual MIT short course on formulation studies during her time at the FDA. Dr. Jia also played a pivotal role in developing breakthrough therapy policies at the FDA and is highly knowledgeable about the regulatory requirements for fast track and breakthrough requests, as well as drug development via expedited pathways. Academically, Dr. Jia holds a master's degree in Bioscience Regulatory Affairs from Johns Hopkins University and a Ph.D. in Microbiology and Molecular Genetics from Emory University. She earned her bachelor’s degree in medicine from Peking University, passed the USMLE, and obtained her ECFMG certification for foreign medical graduates.

Katie is pursuing a B.S. in Economics at the Wharton School and an M.S. in Scientific Computing at the School of Engineering and Applied Science at the University of Pennsylvania. She is also completing a Pre-Medical Post-Baccalaureate at George Washington University.

She has experience supporting and coordinating clinical trials, including patient screening, informed consent, data collection, and specimen handling in collaboration with diagnostic and research teams. Her work integrates clinical operations with analytical problem-solving, enabling efficient execution of study protocols.

Katie oversees financial modeling, operations, and investor relations, bridging technical expertise with business acumen. Her interdisciplinary background spans healthcare, data science, and applied research, supporting innovation at the intersection of medicine and technology.